BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 37106278)

  • 1. Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists.
    Gupta AK; Talukder M; Rosen T; Piguet V
    Am J Clin Dermatol; 2023 Jul; 24(4):541-556. PubMed ID: 37106278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mpox: Rapid Evidence Review.
    Saguil A; Krebs L; Choe U
    Am Fam Physician; 2023 Jul; 108(1):78-83. PubMed ID: 37440743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human monkeypox virus in the shadow of the COVID-19 pandemic.
    Khamees A; Awadi S; Al-Shami K; Alkhoun HA; Al-Eitan SF; Alsheikh AM; Saeed A; Al-Zoubi RM; Zoubi MSA
    J Infect Public Health; 2023 Aug; 16(8):1149-1157. PubMed ID: 37269693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mpox (monkeypox): Diagnosis, prevention, and management in adults.
    Jarrell L; Perryman K
    Nurse Pract; 2023 Apr; 48(4):13-20. PubMed ID: 36975744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management from Primary Care of monkeypox infection (MPOX) in humans].
    Arranz Izquierdo J; Molero García JM; Gutiérrez Pérez MI
    Aten Primaria; 2023 Oct; 55(10):102680. PubMed ID: 37343414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for the Re-Emerging Human Monkeypox Virus.
    Lee W; Kim YJ; Lee SJ; Ahn DG; Kim SJ
    J Microbiol Biotechnol; 2023 Aug; 33(8):981-991. PubMed ID: 37519276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023.
    Rao AK; Schrodt CA; Minhaj FS; Waltenburg MA; Cash-Goldwasser S; Yu Y; Petersen BW; Hutson C; Damon IK
    MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(9):232-243. PubMed ID: 36862595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monkeypox (Mpox) outbreak during COVID-19 pandemic-Past and the future.
    Aden D; Zaheer S; Kumar R; Ranga S
    J Med Virol; 2023 Apr; 95(4):e28701. PubMed ID: 36951352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis.
    Karagoz A; Tombuloglu H; Alsaeed M; Tombuloglu G; AlRubaish AA; Mahmoud A; Smajlović S; Ćordić S; Rabaan AA; Alsuhaimi E
    J Infect Public Health; 2023 Apr; 16(4):531-541. PubMed ID: 36801633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing monkeypox outbreaks: Focus on diagnosis, care, treatment, and vaccination.
    Ghaseminia M
    J Clin Transl Sci; 2023; 7(1):e60. PubMed ID: 37008622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mpox outbreak 2022: an overview of all cases reported to the Cologne Health Department.
    Kröger ST; Lehmann MC; Treutlein M; Fiethe A; Kossow A; Küfer-Weiß A; Nießen J; Grüne B
    Infection; 2023 Oct; 51(5):1369-1381. PubMed ID: 36787016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf.
    De Clercq E; Jiang Y; Li G
    Travel Med Infect Dis; 2023; 52():102528. PubMed ID: 36539022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review to identify novel clinical characteristics of monkeypox virus infection and therapeutic and preventive strategies to combat the virus.
    Chenchula S; Ghanta MK; Amerneni KC; Rajakarunakaran P; Chandra MB; Chavan M; Gupta R
    Arch Virol; 2023 Jun; 168(7):195. PubMed ID: 37386209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study.
    Cohn H; Bloom N; Cai GY; Clark JJ; Tarke A; Bermúdez-González MC; Altman DR; Lugo LA; Lobo FP; Marquez S; ; Chen JQ; Ren W; Qin L; Yates JL; Hunt DT; Lee WT; Crotty S; Krammer F; Grifoni A; Sette A; Simon V; Coelho CH
    Lancet Infect Dis; 2023 Nov; 23(11):1302-1312. PubMed ID: 37475115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.
    Russo AT; Grosenbach DW; Honeychurch KM; Long PG; Hruby DE
    Expert Rev Anti Infect Ther; 2023 Mar; 21(3):235-242. PubMed ID: 36728515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monkeypox outbreak in the post-eradication era of smallpox.
    Kandra NV; Varghese AM; Uppala PK; Uttaravelli U; Lavanya B; Shabana SKM; Somarouthu VS; Balijepalli MK
    Egypt J Intern Med; 2023; 35(1):10. PubMed ID: 36777901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments.
    Soheili M; Nasseri S; Afraie M; Khateri S; Moradi Y; Mahdavi Mortazavi SM; Gilzad-Kohan H
    J Pharm Pharm Sci; 2022; 25():297-322. PubMed ID: 36130588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monkeypox: a global health emergency.
    Stilpeanu RI; Stercu AM; Stancu AL; Tanca A; Bucur O
    Front Microbiol; 2023; 14():1094794. PubMed ID: 37180247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview on mRNA-based vaccines to prevent monkeypox infection.
    Natami M; Gorgzadeh A; Gholipour A; Fatemi SN; Firouzeh N; Zokaei M; Mohammed Ali SH; Kheradjoo H; Sedighi S; Gholizadeh O; Kalavi S
    J Nanobiotechnology; 2024 Mar; 22(1):86. PubMed ID: 38429829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of the Smallpox Vaccine for Postexposure Prophylaxis in Monkeypox: Protocol for an Open-Labeled, Single-Armed Study.
    Yano R; Terada-Hirashima J; Uemura Y; Tomita N; Shimizu Y; Iwasaki H; Okumura N; Suzuki T; Saito S; Ujiie M; Sugiura W; Ohmagari N
    JMIR Res Protoc; 2023 Aug; 12():e46955. PubMed ID: 37624623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.